Crohn Disease (CD)
88
45
46
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 88 trials
100.0%
+13.4% vs benchmark
7%
6 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 12 completed trials
Clinical Trials (88)
HB-adMSCs for the Treatment of Crohn's Disease
INSIGHT-IBD Pragmatic Study
Assessing Interventions of Diet in IBD
Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease.
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives
Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
Cranberry and Gut Health in Crohn's Disease
Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
IBD Biomarker Discovery and Validation Platform
Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study
Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery
Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study
Effect of Isoflavone and Vitamin D Supplementation on Serum Vitamin D Levels, Body Composition, Inflammatory Markers, and Quality of Life in Patients With Inflammatory Bowel Disease
Regenerative Endoscopy in Refractory Perianal Crohn's Disease
Impact of Advanced Crohn's Disease Therapies on Sleep Quality
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort Study